NCT06138470 is a NA clinical trial of Saffron extract in Mood Regulation, sponsored by Comercial Quimica Masso, S.A.

Who is sponsoring NCT06138470?

NCT06138470 is sponsored by Comercial Quimica Masso, S.A.

What drugs are being tested in NCT06138470?

Interventions in NCT06138470: Saffron extract, Scutellaria baicalensis extract, Saffron and Scutellaria baicalensis extract, Placebo (maltodextrin).

What condition does NCT06138470 study?

NCT06138470 studies Mood Regulation.

Is NCT06138470 still recruiting?

NCT06138470 is currently completed. Last updated 29 January 2025.

Last reviewed 2025-01-29 · How we verify

NCT06138470

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Evaluation of the Effect of a Combination of Plants to Regulate Mood

Completed NA Last updated 29 January 2025

What this trial tests

NA trial testing Saffron extract in Mood Regulation in 180 participants. Completed in 30 September 2024.

Timeline

30 May 2022

Primary endpoint
30 July 2024

30 September 2024

Quick facts

Lead sponsor	Comercial Quimica Masso, S.A
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	quadruple
Primary purpose	other
Enrollment	180
Start date	30 May 2022
Primary completion	30 July 2024
Estimated completion	30 September 2024
Sites	1 location across Belgium

Drugs / interventions tested

Saffron extract
Scutellaria baicalensis extract
Saffron and Scutellaria baicalensis extract
Placebo (maltodextrin)

Conditions studied

Mood Regulation — all drugs for Mood Regulation →

Sponsor

Comercial Quimica Masso, S.A

Who can join

Adults 18 to 75, any sex, with Mood Regulation. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The aim of this study is to confirm by a randomized double-blind controlled study the interest of a combination of saffron (Saffr'Activ®) and scutellaria (Scutell'up®) on the regulation of mood.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

The Effects of Combined Scutellaria and Saffron Supplementation on Mood Regulation in Participants with Mild-to-Moderate Depressive Symptoms: A Randomized, Double-Blind, Placebo-Controlled Study.
Dormal V, Suchareau M, Copine S, Simar L, et al · · 2025 · cited 2× · PMID 40077679 · DOI 10.3390/nu17050809

Verify or expand the search:

Other Comercial Quimica Masso, S.A trials

Trials by the same sponsor.

NCT04750681 — Evaluation of the Effects of Saffron Extract on Sleep Quality and Stress · NA · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT06138470 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Comercial Quimica Masso, S.A
Last refreshed: 29 January 2025

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06138470.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing